Annual CFO:
-$3.00B+$114.00M(+3.66%)Summary
- As of today, MRNA annual cash from operations is -$3.00 billion, with the most recent change of +$114.00 million (+3.66%) on December 31, 2024.
- During the last 3 years, MRNA annual cash from operations has fallen by -$16.62 billion (-122.06%).
- MRNA annual cash from operations is now -122.06% below its all-time high of $13.62 billion, reached on December 31, 2021.
Performance
MRNA Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly CFO:
-$847.00M+$72.00M(+7.83%)Summary
- As of today, MRNA quarterly cash from operations is -$847.00 million, with the most recent change of +$72.00 million (+7.83%) on September 30, 2025.
- Over the past year, MRNA quarterly cash from operations has increased by +$719.00 million (+45.91%).
- MRNA quarterly cash from operations is now -120.85% below its all-time high of $4.06 billion, reached on June 30, 2021.
Performance
MRNA Quarterly Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFO:
-$1.98B+$719.00M(+26.66%)Summary
- As of today, MRNA TTM cash from operations is -$1.98 billion, with the most recent change of +$719.00 million (+26.66%) on September 30, 2025.
- Over the past year, MRNA TTM cash from operations has increased by +$1.23 billion (+38.32%).
- MRNA TTM cash from operations is now -114.52% below its all-time high of $13.62 billion, reached on December 31, 2021.
Performance
MRNA TTM Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
MRNA Cash From Operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +3.7% | +45.9% | +38.3% |
| 3Y3 Years | -122.1% | -436.1% | -129.8% |
| 5Y5 Years | -554.5% | -194.9% | -397.6% |
MRNA Cash From Operations Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -122.1% | +3.7% | -151.0% | +47.1% | -129.8% | +39.0% |
| 5Y | 5-Year | -122.1% | +3.7% | -120.8% | +47.1% | -114.5% | +39.0% |
| All-Time | All-Time | -122.1% | +3.7% | -120.8% | +47.1% | -114.5% | +39.0% |
MRNA Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | -$847.00M(+7.8%) | -$1.98B(+26.7%) |
| Jun 2025 | - | -$919.00M(+11.4%) | -$2.70B(+11.6%) |
| Mar 2025 | - | -$1.04B(-225.7%) | -$3.05B(-1.6%) |
| Dec 2024 | -$3.00B(+3.7%) | $825.00M(+152.7%) | -$3.00B(+6.3%) |
| Sep 2024 | - | -$1.57B(-22.9%) | -$3.21B(+1.0%) |
| Jun 2024 | - | -$1.27B(-28.8%) | -$3.24B(-12.5%) |
| Mar 2024 | - | -$989.00M(-259.0%) | -$2.88B(+7.6%) |
| Dec 2023 | -$3.12B(-162.6%) | $622.00M(+138.9%) | -$3.12B(-50.0%) |
| Sep 2023 | - | -$1.60B(-74.9%) | -$2.08B(-819.5%) |
| Jun 2023 | - | -$915.00M(+25.3%) | -$226.00M(-122.8%) |
| Mar 2023 | - | -$1.23B(-173.7%) | $993.00M(-80.1%) |
| Dec 2022 | $4.98B(-63.4%) | $1.66B(+559.5%) | $4.98B(-24.9%) |
| Sep 2022 | - | $252.00M(-17.1%) | $6.63B(-31.3%) |
| Jun 2022 | - | $304.00M(-89.0%) | $9.65B(-28.0%) |
| Mar 2022 | - | $2.76B(-16.5%) | $13.41B(-1.5%) |
| Dec 2021 | $13.62B(+571.9%) | $3.31B(+1.0%) | $13.62B(+17.7%) |
| Sep 2021 | - | $3.28B(-19.4%) | $11.57B(+25.9%) |
| Jun 2021 | - | $4.06B(+36.8%) | $9.19B(+80.1%) |
| Mar 2021 | - | $2.97B(+135.0%) | $5.10B(+151.8%) |
| Dec 2020 | $2.03B(+541.6%) | $1.26B(+41.6%) | $2.03B(+205.0%) |
| Sep 2020 | - | $892.75M(+3839.3%) | $664.63M(+298.3%) |
| Jun 2020 | - | -$23.88M(+77.5%) | -$335.21M(+20.2%) |
| Mar 2020 | - | -$106.19M(-8.3%) | -$419.92M(+8.3%) |
| Dec 2019 | -$459.00M(-38.7%) | -$98.05M(+8.4%) | -$458.00M(-1.6%) |
| Sep 2019 | - | -$107.09M(+1.4%) | -$450.97M(-5.9%) |
| Jun 2019 | - | -$108.58M(+24.7%) | -$425.83M(-17.1%) |
| Mar 2019 | - | -$144.27M(-58.5%) | -$363.75M(-9.9%) |
| Dec 2018 | -$330.87M(+0.2%) | -$91.02M(-11.1%) | -$330.87M(+3.5%) |
| Sep 2018 | - | -$81.96M(-76.2%) | -$342.77M(-31.3%) |
| Jun 2018 | - | -$46.50M(+58.3%) | -$261.00M(-21.5%) |
| Mar 2018 | - | -$111.39M(-8.2%) | -$214.87M(-106.9%) |
| Dec 2017 | -$331.48M(-596.7%) | -$102.93M(>-9900.0%) | -$103.85M(-8935.2%) |
| Sep 2017 | - | -$190.70K(+48.2%) | -$1.15M(-15.5%) |
| Jun 2017 | - | -$368.50K(-1.2%) | -$995.30K(-40.9%) |
| Mar 2017 | - | -$364.00K(-60.9%) | -$706.50K(-35.2%) |
| Dec 2016 | $66.73M(+3182.4%) | - | - |
| Dec 2016 | - | -$226.20K(-518.0%) | -$522.40K(+38.8%) |
| Sep 2016 | - | -$36.60K(+54.1%) | -$854.20K(+35.6%) |
| Jun 2016 | - | -$79.70K(+55.7%) | -$1.33M(+21.2%) |
| Mar 2016 | - | -$179.90K(+67.8%) | -$1.68M(+22.3%) |
| Dec 2015 | -$2.17M(+54.7%) | -$558.00K(-9.8%) | -$2.17M(+28.0%) |
| Sep 2015 | - | -$508.00K(-16.2%) | -$3.01M(+16.7%) |
| Jun 2015 | - | -$437.00K(+34.0%) | -$3.61M(+17.5%) |
| Mar 2015 | - | -$662.00K(+52.8%) | -$4.38M(+8.4%) |
| Dec 2014 | -$4.78M(-1776.8%) | -$1.40M(-26.2%) | -$4.78M(-63.8%) |
| Sep 2014 | - | -$1.11M(+7.5%) | -$2.92M(-85.4%) |
| Jun 2014 | - | -$1.20M(-12.8%) | -$1.57M(-451.9%) |
| Mar 2014 | - | -$1.06M(-331.5%) | -$285.00K(-200.0%) |
| Dec 2013 | $285.00K(+106.5%) | $460.00K(+97.4%) | $285.00K(+133.9%) |
| Sep 2013 | - | $233.00K(+167.8%) | -$840.00K(+36.7%) |
| Jun 2013 | - | $87.00K(+117.6%) | -$1.33M(+22.4%) |
| Mar 2013 | - | -$495.00K(+25.6%) | -$1.71M(+61.1%) |
| Dec 2012 | -$4.39M(+72.8%) | -$665.00K(-162.8%) | -$4.39M(+22.3%) |
| Sep 2012 | - | -$253.00K(+14.2%) | -$5.65M(+44.4%) |
| Jun 2012 | - | -$295.00K(+90.7%) | -$10.16M(+31.3%) |
| Mar 2012 | - | -$3.18M(-65.3%) | -$14.79M(+8.3%) |
| Dec 2011 | -$16.12M(+4.1%) | -$1.92M(+59.7%) | -$16.12M(+5.3%) |
| Sep 2011 | - | -$4.76M(+3.2%) | -$17.02M(+1.5%) |
| Jun 2011 | - | -$4.92M(-9.1%) | -$17.29M(-2.3%) |
| Mar 2011 | - | -$4.51M(-59.4%) | -$16.90M(-0.6%) |
| Dec 2010 | -$16.80M(-123.3%) | -$2.83M(+43.8%) | -$16.80M(+5.1%) |
| Sep 2010 | - | -$5.03M(-11.1%) | -$17.70M(-1.7%) |
| Jun 2010 | - | -$4.53M(-2.7%) | -$17.40M(+9.0%) |
| Mar 2010 | - | -$4.41M(-18.3%) | -$19.12M(-154.0%) |
| Dec 2009 | -$7.53M | -$3.73M(+21.3%) | -$7.53M(+23.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2009 | - | -$4.74M(+24.1%) | -$9.87M(+23.5%) |
| Jun 2009 | - | -$6.24M(-186.9%) | -$12.91M(+24.7%) |
| Mar 2009 | - | $7.18M(+218.3%) | -$17.13M(+57.7%) |
| Dec 2008 | -$40.47M(+12.9%) | -$6.07M(+21.9%) | -$40.47M(+17.8%) |
| Sep 2008 | - | -$7.78M(+25.7%) | -$49.25M(+8.0%) |
| Jun 2008 | - | -$10.47M(+35.2%) | -$53.51M(+0.1%) |
| Mar 2008 | - | -$16.16M(-8.9%) | -$53.57M(-15.3%) |
| Dec 2007 | -$46.46M(-214.9%) | -$14.84M(-23.3%) | -$46.46M(-21.0%) |
| Sep 2007 | - | -$12.04M(-14.3%) | -$38.39M(-14.8%) |
| Jun 2007 | - | -$10.53M(-16.3%) | -$33.45M(-65.7%) |
| Mar 2007 | - | -$9.05M(-33.6%) | -$20.18M(-36.8%) |
| Dec 2006 | -$14.75M(+52.8%) | -$6.78M(+4.5%) | -$14.75M(+7.1%) |
| Sep 2006 | - | -$7.09M(-359.2%) | -$15.89M(+14.2%) |
| Jun 2006 | - | $2.74M(+175.6%) | -$18.52M(+35.3%) |
| Mar 2006 | - | -$3.62M(+54.2%) | -$28.61M(+8.5%) |
| Dec 2005 | -$31.28M(-63.2%) | -$7.91M(+18.6%) | -$31.28M(-42.1%) |
| Sep 2005 | - | -$9.72M(-32.3%) | -$22.02M(-18.7%) |
| Jun 2005 | - | -$7.35M(-16.7%) | -$18.55M(-6.3%) |
| Mar 2005 | - | -$6.30M(-565.3%) | -$17.46M(+8.9%) |
| Dec 2004 | -$19.17M(-149.4%) | $1.35M(+121.6%) | -$19.17M(+28.3%) |
| Sep 2004 | - | -$6.26M(-0.1%) | -$26.71M(-1.1%) |
| Jun 2004 | - | -$6.26M(+21.8%) | -$26.42M(-7.0%) |
| Mar 2004 | - | -$8.01M(-29.2%) | -$24.70M(-221.3%) |
| Dec 2003 | -$7.69M(-18.2%) | -$6.19M(-3.8%) | -$7.69M(-24.1%) |
| Sep 2003 | - | -$5.97M(-31.7%) | -$6.19M(-108.9%) |
| Jun 2003 | - | -$4.53M(-150.3%) | -$2.96M(-206.9%) |
| Mar 2003 | - | $9.01M(+291.6%) | $2.77M(+142.7%) |
| Dec 2002 | -$6.50M(+11.7%) | -$4.70M(-71.7%) | -$6.50M(-31.1%) |
| Sep 2002 | - | -$2.74M(-326.7%) | -$4.96M(-64.8%) |
| Jun 2002 | - | $1.21M(+545.8%) | -$3.01M(+50.7%) |
| Mar 2002 | - | -$271.00K(+91.4%) | -$6.11M(+17.1%) |
| Dec 2001 | -$7.37M(+6.3%) | -$3.16M(-300.3%) | -$7.37M(-27.0%) |
| Sep 2001 | - | -$789.00K(+58.3%) | -$5.80M(+14.9%) |
| Jun 2001 | - | -$1.89M(-23.7%) | -$6.81M(-16.9%) |
| Mar 2001 | - | -$1.53M(+3.8%) | -$5.83M(+25.9%) |
| Dec 2000 | -$7.86M(-48.3%) | -$1.59M(+11.8%) | -$7.86M(+3.8%) |
| Sep 2000 | - | -$1.80M(-99.1%) | -$8.17M(-10.9%) |
| Jun 2000 | - | -$905.00K(+74.6%) | -$7.37M(+6.3%) |
| Mar 2000 | - | -$3.56M(-87.6%) | -$7.87M(-48.4%) |
| Dec 1999 | -$5.30M(-103.8%) | -$1.90M(-90.0%) | -$5.30M(-29.3%) |
| Sep 1999 | - | -$1.00M(+28.6%) | -$4.10M(-32.3%) |
| Jun 1999 | - | -$1.40M(-40.0%) | -$3.10M(-55.0%) |
| Mar 1999 | - | -$1.00M(-42.9%) | -$2.00M(+23.1%) |
| Dec 1998 | -$2.60M(+18.8%) | -$700.00K(>-9900.0%) | -$2.60M(+3.7%) |
| Sep 1998 | - | $0.00(+100.0%) | -$2.70M(+28.9%) |
| Jun 1998 | - | -$300.00K(+81.3%) | -$3.80M(+13.6%) |
| Mar 1998 | - | -$1.60M(-100.0%) | -$4.40M(-37.5%) |
| Dec 1997 | -$3.20M(-540.0%) | -$800.00K(+27.3%) | -$3.20M(-33.3%) |
| Sep 1997 | - | -$1.10M(-22.2%) | -$2.40M(-33.3%) |
| Jun 1997 | - | -$900.00K(-125.0%) | -$1.80M(-200.0%) |
| Mar 1997 | - | -$400.00K(+20.0%) | -$600.00K(-20.0%) |
| Dec 1996 | -$500.00K(-600.0%) | - | - |
| Sep 1996 | - | -$500.00K(-266.7%) | -$500.00K(-600.0%) |
| Jun 1996 | $100.00K(0.0%) | $300.00K(+400.0%) | $100.00K(+150.0%) |
| Mar 1996 | - | -$100.00K(+50.0%) | -$200.00K(-100.0%) |
| Dec 1995 | - | -$200.00K(-300.0%) | -$100.00K(-200.0%) |
| Sep 1995 | - | $100.00K(>+9900.0%) | $100.00K(0.0%) |
| Jun 1995 | $100.00K(0.0%) | $0.00(0.0%) | $100.00K(0.0%) |
| Mar 1995 | - | $0.00(0.0%) | $100.00K(+200.0%) |
| Dec 1994 | - | $0.00(-100.0%) | -$100.00K(-200.0%) |
| Sep 1994 | - | $100.00K(>+9900.0%) | $100.00K(0.0%) |
| Jun 1994 | $100.00K | $0.00(+100.0%) | $100.00K(0.0%) |
| Mar 1994 | - | -$200.00K(-200.0%) | $100.00K(-66.7%) |
| Dec 1993 | - | $200.00K(+100.0%) | $300.00K(+200.0%) |
| Sep 1993 | - | $100.00K | $100.00K |
FAQ
- What is Moderna, Inc. annual cash from operations?
- What is the all-time high annual cash from operations for Moderna, Inc.?
- What is Moderna, Inc. annual cash from operations year-on-year change?
- What is Moderna, Inc. quarterly cash from operations?
- What is the all-time high quarterly cash from operations for Moderna, Inc.?
- What is Moderna, Inc. quarterly cash from operations year-on-year change?
- What is Moderna, Inc. TTM cash from operations?
- What is the all-time high TTM cash from operations for Moderna, Inc.?
- What is Moderna, Inc. TTM cash from operations year-on-year change?
What is Moderna, Inc. annual cash from operations?
The current annual cash from operations of MRNA is -$3.00B
What is the all-time high annual cash from operations for Moderna, Inc.?
Moderna, Inc. all-time high annual cash from operations is $13.62B
What is Moderna, Inc. annual cash from operations year-on-year change?
Over the past year, MRNA annual cash from operations has changed by +$114.00M (+3.66%)
What is Moderna, Inc. quarterly cash from operations?
The current quarterly cash from operations of MRNA is -$847.00M
What is the all-time high quarterly cash from operations for Moderna, Inc.?
Moderna, Inc. all-time high quarterly cash from operations is $4.06B
What is Moderna, Inc. quarterly cash from operations year-on-year change?
Over the past year, MRNA quarterly cash from operations has changed by +$719.00M (+45.91%)
What is Moderna, Inc. TTM cash from operations?
The current TTM cash from operations of MRNA is -$1.98B
What is the all-time high TTM cash from operations for Moderna, Inc.?
Moderna, Inc. all-time high TTM cash from operations is $13.62B
What is Moderna, Inc. TTM cash from operations year-on-year change?
Over the past year, MRNA TTM cash from operations has changed by +$1.23B (+38.32%)